-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $453 at Citi
-
-
-
-
-
-
-
Bernstein on BeOne Medicines (ONC): 'A Good Opportunity to Buy Now'
-
-
-
-
-
-
-
BofA on BeOne Medicines (ONC): 'we prefer BeOne, given the BTK leadership of Brukinsa and catalyst of BTK CDAC data readout'
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $420 at Jefferies
-
-
-
-
-
-
-
Barclays Starts BeOne Medicines (ONC) at Overweight
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $365 at Guggenheim
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on BeOne Medicines (ONC)
-
423,314 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

